AVTR Should I Buy
-
$
0.000
0.000(0.000%)
At close0.000(0.000%)Aft-market
ET
Avantor Inc (AVTR) is not a strong buy for a beginner investor with a long-term strategy at this time. The stock is facing declining financial performance, negative sentiment from analysts, and lacks significant positive catalysts. While technical indicators are neutral, the absence of strong trading signals and the lack of recent positive developments make it prudent to hold off on investing in this stock.
The MACD is positive but contracting, RSI is neutral at 66.883, and moving averages are converging, indicating no clear trend. The stock is trading near its pivot level of 8.05, with resistance at 8.394 and support at 7.707.
Avantor has enhanced its St. Louis manufacturing site with advanced microbial and stability testing, which could improve quality control for biopharma manufacturing.
Declining financial performance in Q4 2025, with revenue down 1.36% YoY, net income down 89.53% YoY, and EPS down 89.04% YoY. Analysts have consistently lowered price targets and ratings, citing share losses, lack of investment, and management concerns. Sentiment is at all-time lows, and there is no significant hedge fund or insider activity.
Avantor's Q4 2025 financials show significant declines: revenue dropped to $1.66 billion (-1.36% YoY), net income fell to $52.4 million (-89.53% YoY), EPS decreased to $0.08 (-89.04% YoY), and gross margin dropped to 31.49% (-5.63% YoY).
Analysts have a negative outlook on Avantor. Barclays recently lowered its price target to $7 and maintains an Underweight rating. Other firms like Evercore ISI, Morgan Stanley, and Citi have also reduced price targets, reflecting concerns about the company's performance and future prospects.
